Global Human Microbiome Competitive Landscape Professional Research Report 2025
Description
Global Human Microbiome Competitive Landscape Professional Research Report 2025
Research Summary
The human microbiome refers to the diverse and complex community of microorganisms, including bacteria, viruses, fungi, and other microbes, that inhabit various parts of the human body, such as the skin, mouth, gut, and other mucosal surfaces. This microbial ecosystem plays a crucial role in maintaining health by contributing to digestion, nutrient absorption, immune system development, and protection against harmful pathogens. The composition of the human microbiome is highly individualized, influenced by factors such as genetics, diet, environment, and lifestyle. Imbalances in the microbiome, known as dysbiosis, have been linked to various health conditions, including autoimmune diseases, gastrointestinal disorders, and metabolic disorders. Ongoing research in microbiome science is uncovering the intricate relationships between the microbiome and human health, with potential implications for personalized medicine and therapeutic interventions.
According to DIResearch's in-depth investigation and research, the global Human Microbiome market size was valued at XX Million USD in 2024 and is projected to reach XX Million USD by 2032, with a CAGR of XX% (2025-2032). Notably, the China market has changed rapidly in the past few years. By 2024, China's market size is expected to be XX Million USD, representing approximately XX% of the global market share. By 2032, it is anticipated to grow further to XX Million USD, contributing XX% to the worldwide market share.
The major global manufacturers of Human Microbiome include Vedanta, Seres Therapeutics, Second Genome, Rebiotix, ActoGeniX, Enterome BioScience, AvidBiotics, 4D Pharma Research Ltd, Enterologics, Metabogen, Ritter Pharmaceuticals, Metabiomics, Osel, Symberix, Miomics, Symbiotix Biotherapies, MicroBiome Therapeutics LLC etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of Human Microbiome. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Human Microbiome market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.
The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Human Microbiome market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Human Microbiome industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Manufacturers of Human Microbiome Include:
Vedanta
Seres Therapeutics
Second Genome
Rebiotix
ActoGeniX
Enterome BioScience
AvidBiotics
4D Pharma Research Ltd
Enterologics
Metabogen
Ritter Pharmaceuticals
Metabiomics
Osel
Symberix
Miomics
Symbiotix Biotherapies
MicroBiome Therapeutics LLC
Human Microbiome Product Segment Include:
Gastrointestinal Tract Human Micobiome
Urogenital Tract Human Micobiome
Others
Human Microbiome Product Application Include:
Treatment
Diagnosis
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends
Chapter 2: Global Human Microbiome Industry PESTEL Analysis
Chapter 3: Global Human Microbiome Industry Porter’s Five Forces Analysis
Chapter 4: Global Human Microbiome Major Regional Market Size and Forecast Analysis
Chapter 5: Global Human Microbiome Market Size and Forecast by Type and Application Analysis
Chapter 6: North America Passenger Human Microbiome Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 7: Europe Human Microbiome Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 8: China Human Microbiome Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 9: APAC (Excl. China) Human Microbiome Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 10: Latin America Human Microbiome Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 11: Middle East and Africa Human Microbiome Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 12: Global Human Microbiome Competitive Analysis of Key Manufacturers (Revenue, Market Share, Regional Distribution and Industry Concentration)
Chapter 13: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)
Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers
Chapter 15: Research Findings and Conclusion
Chapter 16: Methodology and Data Sources
Table of Contents
170 Pages
- 1 Human Microbiome Market Overview
- 1.1 Product Definition and Statistical Scope
- 1.2 Human Microbiome Product by Type
- 1.2.1 Gastrointestinal Tract Human Micobiome
- 1.2.2 Urogenital Tract Human Micobiome
- 1.2.3 Others
- 1.3 Human Microbiome Product by Application
- 1.3.1 Treatment
- 1.3.2 Diagnosis
- 1.4 Global Human Microbiome Market Size Analysis (2020-2032)
- 1.5 Human Microbiome Market Development Status and Trends
- 1.5.1 Human Microbiome Industry Development Status Analysis
- 1.5.2 Human Microbiome Industry Development Trends Analysis
- 2 Human Microbiome Market PESTEL Analysis
- 2.1 Political Factors Analysis
- 2.2 Economic Factors Analysis
- 2.3 Social Factors Analysis
- 2.4 Technological Factors Analysis
- 2.5 Environmental Factors Analysis
- 2.6 Legal Factors Analysis
- 3 Human Microbiome Market Porter's Five Forces Analysis
- 3.1 Competitive Rivalry
- 3.2 Threat of New Entrants
- 3.3 Bargaining Power of Suppliers
- 3.4 Bargaining Power of Buyers
- 3.5 Threat of Substitutes
- 4 Global Human Microbiome Market Analysis by Regions
- 4.1 Human Microbiome Overall Market: 2024 VS 2025 VS 2032
- 4.2 Global Human Microbiome Revenue and Forecast Analysis (2020-2032)
- 4.2.1 Global Human Microbiome Revenue and Market Share by Region (2020-2025)
- 4.2.2 Global Human Microbiome Revenue Forecast by Region (2026-2032)
- 5 Global Human Microbiome Market Size by Type and Application
- 5.1 Global Human Microbiome Market Size by Type (2020-2032)
- 5.2 Global Human Microbiome Market Size by Application (2020-2032)
- 6 North America
- 6.1 North America Human Microbiome Market Size and Growth Rate Analysis (2020-2032)
- 6.2 North America Key Manufacturers Analysis
- 6.3 North America Human Microbiome Market Size by Type
- 6.4 North America Human Microbiome Market Size by Application
- 6.5 North America Human Microbiome Market Size by Country
- 6.5.1 US
- 6.5.2 Canada
- 7 Europe
- 7.1 Europe Human Microbiome Market Size and Growth Rate Analysis (2020-2032)
- 7.2 Europe Key Manufacturers Analysis
- 7.3 Europe Human Microbiome Market Size by Type
- 7.4 Europe Human Microbiome Market Size by Application
- 7.5 Europe Human Microbiome Market Size by Country
- 7.5.1 Germany
- 7.5.2 France
- 7.5.3 United Kingdom
- 7.5.4 Italy
- 7.5.5 Spain
- 7.5.6 Benelux
- 8 China
- 8.1 China Human Microbiome Market Size and Growth Rate Analysis (2020-2032)
- 8.2 China Key Manufacturers Analysis
- 8.3 China Human Microbiome Market Size by Type
- 8.4 China Human Microbiome Market Size by Application
- 9 APAC (excl. China)
- 9.1 APAC (excl. China) Human Microbiome Market Size and Growth Rate Analysis (2020-2032)
- 9.2 APAC (excl. China) Key Manufacturers Analysis
- 9.3 APAC (excl. China) Human Microbiome Market Size by Type
- 9.4 APAC (excl. China) Human Microbiome Market Size by Application
- 9.5 APAC (excl. China) Human Microbiome Market Size by Country
- 9.5.1 Japan
- 9.5.2 South Korea
- 9.5.3 India
- 9.5.4 Australia
- 9.5.5 Southeast Asia
- 10 Latin America
- 10.1 Latin America Human Microbiome Market Size and Growth Rate Analysis (2020-2032)
- 10.2 Latin America Key Manufacturers Analysis
- 10.3 Latin America Human Microbiome Market Size by Type
- 10.4 Latin America Human Microbiome Market Size by Application
- 10.5 Latin America Human Microbiome Market Size by Country
- 10.5.1 Mexico
- 10.5.2 Brazil
- 11 Middle East & Africa
- 11.1 Middle East & Africa Human Microbiome Market Size and Growth Rate Analysis (2020-2032)
- 11.2 Middle East & Africa Key Manufacturers Analysis
- 11.3 Middle East & Africa Human Microbiome Market Size by Type
- 11.4 Middle East & Africa Human Microbiome Market Size by Application
- 11.5 Middle East & Africa Human Microbiome Market Size by Country
- 11.5.1 Saudi Arabia
- 11.5.2 South Africa
- 12 Competition by Manufacturers
- 12.1 Global Human Microbiome Market Revenue by Key Manufacturers (2021-2025)
- 12.2 Human Microbiome Competitive Landscape Analysis and Market Dynamic
- 12.2.1 Human Microbiome Competitive Landscape Analysis
- 12.2.2 Global Key Manufacturers Headquarter Location and Key Area Sales
- 12.2.3 Market Dynamic
- 13 Key Companies Analysis
- 13.1 Vedanta
- 13.1.1 Vedanta Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.1.2 Vedanta Human Microbiome Product Portfolio
- 13.1.3 Vedanta Human Microbiome Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.2 Seres Therapeutics
- 13.2.1 Seres Therapeutics Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.2.2 Seres Therapeutics Human Microbiome Product Portfolio
- 13.2.3 Seres Therapeutics Human Microbiome Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.3 Second Genome
- 13.3.1 Second Genome Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.3.2 Second Genome Human Microbiome Product Portfolio
- 13.3.3 Second Genome Human Microbiome Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.4 Rebiotix
- 13.4.1 Rebiotix Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.4.2 Rebiotix Human Microbiome Product Portfolio
- 13.4.3 Rebiotix Human Microbiome Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.5 ActoGeniX
- 13.5.1 ActoGeniX Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.5.2 ActoGeniX Human Microbiome Product Portfolio
- 13.5.3 ActoGeniX Human Microbiome Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.6 Enterome BioScience
- 13.6.1 Enterome BioScience Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.6.2 Enterome BioScience Human Microbiome Product Portfolio
- 13.6.3 Enterome BioScience Human Microbiome Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.7 AvidBiotics
- 13.7.1 AvidBiotics Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.7.2 AvidBiotics Human Microbiome Product Portfolio
- 13.7.3 AvidBiotics Human Microbiome Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.8 4D Pharma Research Ltd
- 13.8.1 4D Pharma Research Ltd Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.8.2 4D Pharma Research Ltd Human Microbiome Product Portfolio
- 13.8.3 4D Pharma Research Ltd Human Microbiome Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.9 Enterologics
- 13.9.1 Enterologics Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.9.2 Enterologics Human Microbiome Product Portfolio
- 13.9.3 Enterologics Human Microbiome Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.10 Metabogen
- 13.10.1 Metabogen Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.10.2 Metabogen Human Microbiome Product Portfolio
- 13.10.3 Metabogen Human Microbiome Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.11 Ritter Pharmaceuticals
- 13.11.1 Ritter Pharmaceuticals Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.11.2 Ritter Pharmaceuticals Human Microbiome Product Portfolio
- 13.11.3 Ritter Pharmaceuticals Human Microbiome Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.12 Metabiomics
- 13.12.1 Metabiomics Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.12.2 Metabiomics Human Microbiome Product Portfolio
- 13.12.3 Metabiomics Human Microbiome Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.13 Osel
- 13.13.1 Osel Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.13.2 Osel Human Microbiome Product Portfolio
- 13.13.3 Osel Human Microbiome Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.14 Symberix
- 13.14.1 Symberix Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.14.2 Symberix Human Microbiome Product Portfolio
- 13.14.3 Symberix Human Microbiome Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.15 Miomics
- 13.15.1 Miomics Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.15.2 Miomics Human Microbiome Product Portfolio
- 13.15.3 Miomics Human Microbiome Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.16 Symbiotix Biotherapies
- 13.16.1 Symbiotix Biotherapies Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.16.2 Symbiotix Biotherapies Human Microbiome Product Portfolio
- 13.16.3 Symbiotix Biotherapies Human Microbiome Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.17 MicroBiome Therapeutics LLC
- 13.17.1 MicroBiome Therapeutics LLC Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.17.2 MicroBiome Therapeutics LLC Human Microbiome Product Portfolio
- 13.17.3 MicroBiome Therapeutics LLC Human Microbiome Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 14 Industry Chain Analysis
- 14.1 Human Microbiome Industry Chain Analysis
- 14.2 Human Microbiome Industry Raw Material and Suppliers Analysis
- 14.2.1 Human Microbiome Key Raw Material Supply Analysis
- 14.2.2 Raw Material Suppliers and Contact Information
- 14.3 Human Microbiome Typical Downstream Customers
- 14.4 Human Microbiome Sales Channel Analysis
- 15 Research Findings and Conclusion
- 16 Methodology and Data Source
- 16.1 Methodology/Research Approach
- 16.2 Research Scope
- 16.3 Benchmarks and Assumptions
- 16.4 Date Source
- 16.4.1 Primary Sources
- 16.4.2 Secondary Sources
- 16.5 Data Cross Validation
- 16.6 Disclaimer
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
